FHI Clinical Inc. Expands Support in PREVAIL Research Network

September 17, 2020

FHI Clinical Inc. has announced that it has expanded its support role in the PREVAIL clinical research network, or Partnership for Research on Vaccines and Infectious Diseases in Liberia, to include full operational management. The goal is to sustain the ability of the network’s research-ready sites to conduct research in collaboration with sponsors and research teams, with a focus on emergent and high-impact public health research priorities in Liberia.

FHI Clinical oversees and facilitates the execution and contractual requirements of in-country logistics. These tasks include sourcing, procuring and shipping; all staff hiring; staff training, including good clinical practice, laboratory practices, data management, computer skills, record keeping, etc.; facility management; and renovation project management.

The research network was originally established in 2014 by the Liberian Ministry of Health and U.S. Department of Health and Human Services in response to the 2014-2015 Ebola outbreak.

To read the full release, click here.